Markets:

Overview

News

Currencies

International

Treasuries

MAIA Biotechnology, Inc. Common Stock (NY:MAIA)

1.585 -0.065 (-3.94%)

Streaming Delayed Price Updated: 10:56 AM EST, Jan 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MAIA Biotechnology, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >

MAIA Biotechnology Doses First Patients in Europe in Ongoing Phase 2 Trial (THIO-101) Evaluating THIO for Non-Small Cell Lung Cancer Treatment

March 07, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023 ↗

February 21, 2023

Via Benzinga

ADDING MULTIMEDIA: MAIA Biotechnology’s Telomere-targeting Agent THIO, in Combination With Checkpoint Inhibitor Immune Therapies Atezolizumab (anti-PD-L1) or Pembrolizumab (anti-PD-1), Demonstrated Significantly Greater Tumor Inhibition

February 13, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

Insiders Buying Adamas One And 1 Other Penny Stock ↗

January 30, 2023

The Nasdaq recorded gains for the fourth week in a row. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...

Via Benzinga

Sidoti's January Micro-Cap Conference

January 17, 2023

Via ACCESSWIRE

MAIA Biotechnology Advances New Telomere-Targeting Molecule Program

January 17, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology to Participate in Four Upcoming Investor Conferences

January 05, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

CalAmp And 2 Other Stocks Under $5 Insiders Are Aggressively Buying ↗

December 30, 2022

The Dow Jones settled higher by over 300 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

MAIA Biotechnology Holds Successful Pre-IND Meeting with FDA for Planned US Expansion of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer

December 20, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Expands Phase 2 THIO-101 Trial to Europe

December 13, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Announces Establishment of Rule 10b5-1 Trading Plan

November 22, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Presents Preclinical Data at SITC Annual Meeting Validating Efficacy of THIO in Treating Hepatocellular Carcinoma

November 15, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 09, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

Sidoti's November Micro-Cap Virtual Conference

November 08, 2022

Via ACCESSWIRE

MAIA Biotechnology to Participate in ThinkEquity Conference

October 06, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology to Present at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

September 29, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology to Participate in H.C. Wainwright 24th Annual Global Investment Conference

September 08, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology to Present Design of THIO-101 Trial at European Society for Medical Oncology (ESMO) Congress 2022

September 06, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology to Present Anticancer THIO Platform at XIV International Round Table on Nucleosides, Nucleotides, and Nucleic Acids

August 30, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 22, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

Opening Day: Hong Kong's GigaCloud Jumps In Nasdaq Debut ↗

August 20, 2022

Shares of Hong Kong-based online marketplace provider GigaCloud jumped almost 30% in its debut earlier this week. It opened at $19.20 on Thursday, up 57% from its original price of $12.25 per share....

Via Talk Markets

This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket ↗

August 03, 2022

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday.

Via Benzinga

This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday ↗

August 04, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.

Via Benzinga

Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session ↗

August 03, 2022

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 03, 2022

It's time for another dive into the biggest pre-market stock movers as we check out the latest news investors need to know about Wednesday!

Via InvestorPlace

MAIA Biotechnology Receives FDA Orphan Drug Designation for THIO for the Treatment of Small-Cell Lung Cancer (SCLC)

August 02, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Announces Closing of Initial Public Offering

August 01, 2022

From MAIA Biotechnology, Inc.

Via Business Wire

Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday ↗

August 03, 2022

Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.

Via Benzinga

Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday ↗

August 02, 2022

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.

Via Benzinga

This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session ↗

August 01, 2022

Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.